Mouse otocyst transuterine gene transfer restores hearing in mice with connexin 30 deletion-associated hearing loss

Molecular Therapy

Volumn 21, Issue 6, 2013, Pages 1142-1150

  Miwa, Toru ^a   Minoda, Ryosei ^a   Ise, Momoko ^a   Yamada, Takao ^a   Yumoto, Eiji ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 30; ENHANCED GREEN FLUORESCENT PROTEIN; SHORT HAIRPIN RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CX30 GENE; ELECTROPORATION; EMBRYO; EMBRYO (ANATOMY); FEMALE; GENE; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; GENETIC ASSOCIATION; HEARING IMPAIRMENT; HISTOPATHOLOGY; HOMOZYGOTE; IN VIVO GENE TRANSFER; NONHUMAN; OTOCYST; PROTEIN EXPRESSION; WILD TYPE;

MUS;

EID: 84878585497     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2013.62     Document Type: Article

References (23)

1. Seewald, RC and Tharpe, AM (2011). Comprehensive Handbook of Pediatric Audiology. Plural Pub.: San Diego.
2. Kral, A and O'Donoghue, GM (2010). Profound deafness in childhood. N Engl J Med 363: 1438-1450.
3. Miwa, T, Minoda, R, Kaitsuka, T, Ise, M, Tomizawa, K and Yumoto, E (2011). Protein transduction into the mouse otocyst using arginine-rich cell-penetrating peptides. Neuroreport 22: 994-999.
4. Minoda, R, Kawamoto, K and Raphael, Y. (2003). Trans-utero gene transfer into the mouse otocyst. Assoc Res Otolaryngol 26: 162-163.
5. Bedrosian, JC, Gratton, MA, Brigande, JV, Tang, W, Landau, J and Bennett, J (2006). In vivo delivery of recombinant viruses to the fetal murine cochlea: transduction characteristics and long-term effects on auditory function. Mol Ther 14: 328-335.
6. Gubbels, S P, Woessner, DW, Mitchell, JC, Ricci, AJ and Brigande, JV (2008). Functional auditory hair cells produced in the mammalian cochlea by in utero gene transfer. Nature 455: 537-541.
7. Martínez, AD, Acuña, R, Figueroa, V, Maripillan, J and Nicholson, B (2009). Gap-junction channels dysfunction in deafness and hearing loss. Antioxid Redox Signal 11: 309-322.
8. Cohen-Salmon, M, Ott, T, Michel, V, Hardelin, JP, Perfettini, I, Eybalin, M et al. (2002). Targeted ablation of connexin26 in the inner ear epithelial gap junction network causes hearing impairment and cell death. Curr Biol 12: 1106-1111.
9. Kudo, T, Kure, S, Ikeda, K, Xia, AP, Katori, Y, Suzuki, M et al. (2003). Transgenic expression of a dominant-negative connexin26 causes degeneration of the organ of Corti and non-syndromic deafness. Hum Mol Genet 12: 995-1004.
10. Forge, A, Becker, D, Casalotti, S, Edwards, J, Marziano, N and Nevill, G (2003). Gap junctions in the inner ear: comparison of distribution patterns in different vertebrates and assessment of connexin composition in mammals. J Comp Neurol 467: 207-231.
11. Grifa, A, Wagner, CA, D'Ambrosio, L, Melchionda, S, Bernardi, F, Lopez-Bigas, N et al. (1999). Mutations in GJB6 cause nonsyndromic autosomal dominant deafness at DFNA3 locus. Nat Genet 23: 16-18.
12. Teubner, B, Michel, V, Pesch, J, Lautermann, J, Cohen-Salmon, M, Söhl, G et al. (2003). Connexin30 (Gjb6)-defciency causes severe hearing impairment and lack of endocochlear potential. Hum Mol Genet 12: 13-21.
13. Jan, AY, Amin, S, Ratajczak, P, Richard, G and Sybert, VP (2004). Genetic heterogeneity of KID syndrome: identifcation of a Cx30 gene (GJB6) mutation in a patient with KID syndrome and congenital atrichia. J Invest Dermatol 122: 1108-1113.
14. Sun, J, Ahmad, S, Chen, S, Tang, W, Zhang, Y, Chen, P et al. (2005). Cochlear gap junctions coassembled from Cx26 and 30 show faster intercellular Ca2+ signaling than homomeric counterparts. Am J Physiol, Cell Physiol 288: C613-C623.
15. Smith, RJH, Shearer, AE, Hildebrand, MS and Van Camp, G (1993). Hereditary Hearing Loss Overview. In: Pagon, RA, Bird, TD, Dolan, CR, Stephens, K and Adam, MP (eds). GeneReviews: Seattle, WA.
16. Choi, BY, Kim, HM, Ito, T, Lee, KY, Li, X, Monahan, K et al. (2011). Mouse model of enlarged vestibular aqueducts defnes temporal requirement of Slc26a4 expression for hearing acquisition. J Clin Invest 121: 4516-4525.
17. Everett, LA, Glaser, B, Beck, JC, Idol, JR, Buchs, A, Heyman, M et al. (1997). Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet 17: 411-422.
18. Sun, Y, Tang, W, Chang, Q, Wang, Y, Kong, W and Lin, X (2009). Connexin30 null and conditional connexin26 null mice display distinct pattern and time course of cellular degeneration in the cochlea. J Comp Neurol 516: 569-579.
19. Akil, O, Seal, RP, Burke, K, Wang, C, Alemi, A, During, M et al. (2012). Restoration of hearing in the VGLUT3 knockout mouse using virally mediated gene therapy. Neuron 75: 283-293.
20. Seal, R P, Akil, O, Yi, E, Weber, CM, Grant, L, Yoo, J et al. (2008). Sensorineural deafness and seizures in mice lacking vesicular glutamate transporter 3. Neuron 57: 263-275.
21. Staecker, H, Praetorius, M and Brough, DE (2011). Development of gene therapy for inner ear disease: Using bilateral vestibular hypofunction as a vehicle for translational research. Hear Res 276: 44-51.
22. Aarnisalo, AA, Pietola, L, Joensuu, J, Isosomppi, J, Aarnisalo, P, Dinculescu, A et al. (2007). Anti-clarin-1 AAV-delivered ribozyme induced apoptosis in the mouse cochlea. Hear Res 230: 9-16.
23. Li Duan, M, Bordet, T, Mezzina, M, Kahn, A and Ulfendahl, M (2002). Adenoviral and adeno-associated viral vector mediated gene transfer in the guinea pig cochlea. Neuroreport 13: 1295-1299.